ICP incidence at nearly 3% worldwide, but varies by region: Study
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, including stroke, gene regulation, cancer, and rare...| Liver Disease News
Nesfatin-1 (NF-1), a hormone that may ease cellular stress, reduced injury to the placenta in a mouse model of ICP, a study found.| Liver Disease News
Health Canada has authorized a point-of-care test that may be used to quickly diagnose hepatitis C and monitor treatment response.| Liver Disease News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
Rezdiffra has become the first approved therapy for some people with severe fatty liver disease in the European Union.| Liver Disease News
The FDA has conditionally approved Wegovy (semaglutide) to treat certain people with a serious form of fatty liver disease.| Liver Disease News
Hepatitis B treatment needs a global overhaul to meet the WHO’s goal of eliminating the virus as a public health threat by 2030, per a study.| Liver Disease News
Columnist Kathryn Hudson has been tempted to seek advice from "Dr. Google," but she knows it's a poor substitute for a medical professional.| Liver Disease News
The American Liver Foundation's 2025 Liver Life Walk spotlights Domenic Frappolli of Dallas, who was born with biliary atresia.| Liver Disease News
